Multidrug-resistant tuberculosis in the United Kingdom and Lithuania
Rates of resistance to first- and second-line drugs in multidrug-resistant tuberculosis (MDR-TB) cases in the United Kingdom were studied during 2010-2012. The highest rates for ethambutol, pyrazinamide and aminoglycosides occurred among patients originating in Eastern Europe, of whom 47% were Lithu...
Saved in:
Published in | The international journal of tuberculosis and lung disease Vol. 18; no. 6; pp. 663 - 665 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Paris
International Union Against Tuberculosis and Lung Disease
01.06.2014
International Union against Tuberculosis and Lung Disease |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Rates of resistance to first- and second-line drugs in multidrug-resistant tuberculosis (MDR-TB) cases in the United Kingdom were studied during 2010-2012. The highest rates for ethambutol, pyrazinamide and aminoglycosides occurred among patients originating in Eastern Europe,
of whom 47% were Lithuanian. Rates of resistance to kanamycin were significantly lower (P < 0.0001) in the Lithuanian National TB Register than among Lithuanian patients resident in the United Kingdom (5% vs. 78%). In 2010, the majority of UK patients of Eastern European origin were
located within the London region, whereas in 2011 the majority were located outside this region, a significant change (P = 0.01). |
---|---|
Bibliography: | (R) Medicine - General 1027-3719(20140601)18:6L.663;1- ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1027-3719 1815-7920 |
DOI: | 10.5588/ijtld.13.0342 |